The NDUFAF4 Gene Mitochondrial Complex I Deficiency Genetic Test is a specialized diagnostic examination aimed at detecting mutations in the NDUFAF4 gene, which is crucial for the normal functioning of mitochondrial complex I. Mitochondrial complex I is essential for energy production within cells, and deficiencies in this complex can lead to a range of severe mitochondrial disorders, affecting various bodily systems, particularly the nervous system and muscles.
This test is particularly important for individuals presenting symptoms of mitochondrial disorders, or for those with a family history of such conditions, as it can provide a definitive diagnosis. By analyzing the genetic makeup of an individual, this test identifies specific mutations in the NDUFAF4 gene that are known to cause mitochondrial complex I deficiency.
Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test ensures accuracy and reliability. The cost of the NDUFAF4 Gene Mitochondrial Complex I Deficiency Genetic Test is set at 4400 AED. This investment covers the comprehensive analysis required to detect the presence of genetic mutations associated with the condition, providing crucial information for the management and treatment of affected individuals. It represents a significant step forward in personalized medicine, offering hope and answers to those affected by mitochondrial disorders.
The NDUFAF5 gene plays a crucial role in the proper functioning of mitochondrial complex I, a vital component of the mitochondrial respiratory chain responsible for energy production in cells. Mutations in the NDUFAF5 gene can lead to mitochondrial complex I deficiency, a genetic disorder that affects various body systems, particularly the nervous system and muscles, leading to a wide range of health issues.
To diagnose this condition, a genetic test specifically targeting the NDUFAF5 gene can be conducted. This test is crucial for identifying mutations in the gene, confirming a diagnosis, and guiding treatment and management decisions. It involves collecting a DNA sample, typically through a blood draw, which is then analyzed in a laboratory for any genetic abnormalities associated with mitochondrial complex I deficiency.
In the UAE, DNA Labs UAE offers this specialized genetic test. The cost of the NDUFAF5 Gene Mitochondrial Complex I Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This state-of-the-art facility ensures accurate and reliable testing, employing the latest in genetic testing technology and methodologies. The test not only aids in the diagnosis but also plays a role in family planning and understanding the risk of recurrence in future pregnancies.
The NDUFB3 gene plays a crucial role in the proper functioning of mitochondrial complex I, a key component of the mitochondrial respiratory chain responsible for energy production in cells. Mutations in the NDUFB3 gene can lead to mitochondrial complex I deficiency, a genetic condition that can cause a wide range of clinical symptoms, including neuromuscular disorders and metabolic abnormalities.
To diagnose this condition, a genetic test is available at DNA Labs UAE, which specifically targets the NDUFB3 gene to identify mutations that may result in mitochondrial complex I deficiency. This test is essential for confirming the diagnosis, understanding the disease's progression, and guiding treatment options.
The cost of the NDUFB3 Gene Mitochondrial Complex I Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect mutations in the NDUFB3 gene, providing crucial information for affected individuals and their families.
The "BRWD3 Gene Mental Retardation X-Linked Type 93 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the BRWD3 gene, which are associated with X-Linked Mental Retardation Type 93. This condition is a genetic disorder that primarily affects males, leading to various degrees of intellectual disability and possibly other physical or neurological symptoms. The test plays a crucial role in the early diagnosis and management of the condition, enabling healthcare providers to tailor interventions and support to the needs of the individual.
Performed through a blood sample or cheek swab, the test analyzes the DNA for specific mutations in the BRWD3 gene that are linked to the disorder. It is particularly recommended for families with a history of X-linked mental retardation or for individuals showing related symptoms without a clear diagnosis.
The cost of the test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it provides into the individual's genetic makeup. This information can be invaluable for affected families, offering them a clearer understanding of their genetic conditions and guiding them towards appropriate therapeutic and supportive measures.
The GRIA3 Gene Mental Retardation X-Linked Type 94 Genetic Test is a specialized diagnostic tool designed to identify mutations in the GRIA3 gene, which have been associated with X-linked mental retardation type 94. This condition is a genetic disorder that primarily affects males and is characterized by various degrees of intellectual disability, developmental delays, and in some cases, physical abnormalities or behavioral issues. The GRIA3 gene plays a crucial role in the brain's communication pathways, and mutations in this gene can disrupt normal brain development and function.
This genetic test involves analyzing the DNA to detect any abnormalities in the GRIA3 gene that might indicate the presence of X-linked mental retardation type 94. It is a critical step for families seeking answers about developmental issues in their male children, as a positive identification of a mutation can help in understanding the condition better, planning for the future, and potentially connecting with therapies and support networks tailored to this specific type of intellectual disability.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in the GRIA3 gene. Families considering this test can expect professional guidance, confidentiality, and support throughout the testing process at DNA Labs UAE, ensuring they receive the information needed to make informed decisions about their loved one's care and well-being.
The MAGT1 gene, associated with X-linked mental retardation type 95 (MRX95), plays a critical role in cognitive development and function. Mutations in the MAGT1 gene can lead to various neurological and developmental disorders, prominently featuring intellectual disabilities. Recognizing the importance of early and accurate diagnosis, DNA Labs UAE offers a specialized genetic test aimed at detecting mutations within the MAGT1 gene.
This genetic test is a powerful tool for families and healthcare professionals, providing crucial insights into the genetic underpinnings of intellectual disabilities linked to MRX95. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic alterations in the MAGT1 gene.
Priced at 4400 AED, the test is an investment in understanding and managing the implications of MRX95, offering a pathway towards personalized care plans and interventions. By pinpointing the genetic cause, families can access targeted support and resources, potentially improving outcomes and quality of life for affected individuals. DNA Labs UAE stands at the forefront of genetic diagnostics, providing this essential service with accuracy and confidentiality.
The SYP Gene Mental Retardation X-Linked Type 96 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the SYP gene, which are associated with X-linked mental retardation type 96. This condition is a rare genetic disorder that affects cognitive development and can lead to various degrees of intellectual disability, primarily in males due to its X-linked inheritance pattern. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the SYP gene that could indicate the presence of the disorder.
With a test cost of 4400 AED, the procedure is a critical resource for families seeking answers about intellectual disabilities and related developmental issues. It not only aids in the diagnosis but also helps in understanding the condition's severity and potential management strategies. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and stringent quality controls, this test represents a crucial step towards personalized medicine and provides essential information for affected individuals and their families regarding prognosis and potential genetic counseling needs.
The ZNF711 Gene Mental Retardation X-Linked Type 97 Genetic Test is a specialized diagnostic tool designed to identify mutations in the ZNF711 gene, which is associated with X-linked mental retardation type 97. This condition is characterized by intellectual disabilities that are transmitted through the X chromosome, primarily affecting males. The ZNF711 gene plays a crucial role in brain development and function, and mutations in this gene can lead to a spectrum of cognitive impairments.
The test is conducted at DNA Labs UAE, a state-of-the-art facility equipped with advanced genetic testing technology. By analyzing a sample of the patient's DNA, the test can detect alterations in the ZNF711 gene that are indicative of X-linked mental retardation type 97. This information is vital for understanding the genetic basis of the condition, guiding treatment options, and providing genetic counseling for affected families.
The cost of the ZNF711 Gene Mental Retardation X-Linked Type 97 Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutation responsible for the condition. Early and accurate diagnosis through this genetic test can significantly impact the management and support for individuals with this form of mental retardation, offering insights into potential therapeutic approaches and helping families make informed decisions about care and support.
The USP9X Gene Mental Retardation X-Linked Type 99 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the USP9X gene, which have been associated with X-linked mental retardation type 99. This condition, primarily affecting males due to its X-linked inheritance pattern, is characterized by intellectual disabilities, developmental delays, and sometimes physical abnormalities. The genetic test involves analyzing the patient's DNA to detect any alterations in the USP9X gene that could lead to the condition. With a cost of 4400 AED, this test is crucial for families seeking to understand the genetic underpinnings of intellectual disabilities and for guiding future healthcare and support plans. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure accurate and reliable results for patients and their families.
The ATP6AP2 gene is associated with a rare X-linked form of mental retardation that often presents with epilepsy. Mutations in this gene can lead to a variety of neurological symptoms, including cognitive impairment and seizures. Understanding the genetic basis of these conditions is crucial for accurate diagnosis, management, and treatment.
The genetic test for the ATP6AP2 gene aims to identify mutations that might be responsible for mental retardation and epilepsy in affected individuals. This test is particularly useful for families with a history of these conditions, providing them with vital information that can guide clinical decisions and genetic counseling.
Performed at DNA Labs UAE, the test is available for a cost of 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology to ensure accurate and reliable testing results. The facility adheres to strict quality control measures, providing confidence in the test outcomes. This test represents a significant step forward in the personalized care of individuals with X-linked mental retardation and epilepsy, offering hope for better management and understanding of these complex conditions.
